A clinical overview of paediatric sarcoidosis: Multicentre experience from Turkey

Vafa Guliyeva1, Fatma Gul Demirkan1, Ramazan Emre Yiğit2

  • 1Department of Pediatric Rheumatology, Istanbul School of Medicine, Istanbul University, Istanbul, Türkiye.

Modern Rheumatology
|May 27, 2023
PubMed

Insights

Paediatric sarcoidosis presents with varied symptoms in early-onset (EOS) and late-onset (LOS) forms. Ocular and joint issues are common, but clinical features differ between EOS and LOS patients.

Area of Science:

  • Pediatrics
  • Rheumatology
  • Ophthalmology

Background:

  • Sarcoidosis is a rare multisystem inflammatory disease.
  • Paediatric sarcoidosis (PS) exhibits diverse clinical presentations.
  • Understanding early-onset (EOS) and late-onset (LOS) sarcoidosis is crucial for management.

Purpose of the Study:

  • To characterize demographic data, clinical spectrum, and treatment of paediatric sarcoidosis.
  • To identify variations between early-onset (EOS) and late-onset (LOS) paediatric sarcoidosis.

Main Methods:

  • Retrospective-descriptive study design.
  • Analysis of medical records for paediatric sarcoidosis cases.
  • Comparison of clinical features between EOS and LOS groups.

Main Results:

  • Fifty-two paediatric sarcoidosis cases were analyzed.
  • Ocular symptoms (40.4%), particularly anterior uveitis (55%), were most common.
  • EOS patients showed more joint, eye, and dermatological findings compared to LOS patients.

Conclusions:

  • Paediatric sarcoidosis, both EOS and LOS, presents with variable clinical features.
  • Interdisciplinary collaboration is essential for raising awareness and facilitating early diagnosis.
  • Prompt diagnosis and management can lead to fewer complications in paediatric sarcoidosis.
Abstract

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
282
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
293
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
467
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
182
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
371